MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players
As part of Protisvalor, the research transfer subsidiary of Aix-Marseille University, I have accompanied researchers from the University for nearly 4 years, first to identify European funding opportunities to meet their needs and then to help them develop proposals for submission to the European Commission. As an immunologist, I have participated in all stages of the innovation chain of Marseille Immunopôle, from research to industry and technology transfer. I have always followed R&D projects with particular interest on collaborative projects focused on immunology, involving both scientists, clinicians and industrials.
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players. MI will make us more visible and efficient. Together, we have the unique opportunity to make Marseille metropolis a global hub for fundamental and applied immunology and a capital for immunotherapy R&D. Being involved in this very ambitious project is a privilege and a real responsibility!#ecosystème
As such, we are involved in the Marseille immunology biotope
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.
AMU, AP-HM, CIML
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential.
Our study models help to identify new potential therapeutic targets in preclinical models of personalized medicine.
AMU, IPC, CRCM